Jason Drew Smith
General Counsel, Chief Compliance Officer & Corporate SecretaryMr. Jason Smith J.D. , has been General Counsel, Chief Compliance Officer and Corporate Secretary of UroGen Pharma Ltd. since August 2020. Mr. Smith joined UroGen from Pfizer where he spent the last 11 years. He serves as General Counsel and Chief Compliance Officer at Urogen Pharma, Inc. He joined Pfizer as Chief Counsel, Vaccines, from August 2016 to August 2020 and was subsequently named legal lead for the North American Region of Pfizer Essential Health. Mr. Smith worked at Wyeth, LLC from December 2001 until Pfizer’s acquisition of it in October 2009. He started at Wyeth as antitrust counsel and moved into a Global Product Counsel position in 2005, supporting various brands in the primary care portfolio. In 2008, Mr. Smith was appointed Chief Counsel, U.S. Pharmaceuticals, leading a team of lawyers supporting the prescription pharmaceuticals businesses. Before joining Wyeth, Mr. Smith was an associate at Howrey, Simon, Arnold & White in Washington, DC, in the antitrust and commercial litigation groups. Prior to Howrey, Mr. Smith was a Law Clerk to the Honorable Robert E. Payne of the United States District Court for the Eastern District of Virginia, Richmond Division from August 1997 to August 1998. He received his bachelor’s degree in Economics, cum laude, from Binghamton University and his Doctor of Jurisprudence degree, with high honors, from George Washington University. From October 2009 to August 2016, Mr. Smith acted as counsel for several Pfizer business, including Vaccines and Essential Health. Mr. Smith, from September 1998 to December 2001, was an associate at Howrey, Simon, Arnold & White in Washington, DC, in the antitrust and commercial litigation groups.
Positions
- Company NameUroGen Pharma Ltd.Stock CodeURGNPositionGeneral Counsel, Chief Compliance Officer & Corporate SecretaryColleagues
- EAElizabeth A. BarrettPresident, CEO & Director
- ASArie S. BelldegrunIndependent Chairman
- MPMark P. SchoenbergChief Medical Officer
- CDChristopher DegnanChief Financial Officer
- VIVincent I. PerroneSenior Director of Investor Relations
- HLHerbert LeporChairman of Scientific Advisory Board
- CMCynthia Marie ButittaIndependent Director
- LSLeana S. WenIndependent Director
